Sign up for IDCM newsletter. Sign Up
Original Article

Evaluation of Tenofovir Disoproxil Fumarate Treatment in Patients with Chronic Hepatitis B

Petek Konya and Neşe Demirtürk

Chronic hepatitis B (CHB) is one of the major causes of chronic liver diseases worldwide. Around 296 million people were living with chronic hepatitis B infection in 2019, with 1.5 million new infections each year and more than 820 thousand people losing their life because of hepatitis B virus (HBV) related complications.  Chronic HBV (...) Read More

Original Article

Retrospective Evaluation of Risk Factors for Invasive Candida Infections in a Medical Intensive Care Unit

Mehmet Kürşat Bilgin and others

Fungal infections account for about 20% of all microbiological infections in critically ill patients. Candida species are the most common fungi in intensive care units (ICU) and mostly C. albicans. However, the rate of non-albicans Candida species such as C. tropicalis, C. krusei, C. parapsilosis, C. glabrata which are more resistant to antifungal therapy (...) Read More

Pediatric Cases with Acute Severe Hepatitis of Unknown Origin: Summary of Special Session “Acute Severe Hepatitis of Unknown Etiology in Children” at the 32nd ECCMID in Lisbon, Portugal
Early Release - Commentary: Emerging News from ECCMID 2022

Pediatric Cases with Acute Severe Hepatitis of Unknown Origin: Summary of Special Session “Acute Severe Hepatitis of Unknown Etiology in Children” at the 32nd ECCMID in Lisbon, Portugal

Gülşen Özkaya Şahin and others

Following the increase in number of pediatric cases with acute severe hepatitis of unknown etiology (ASHep-UE), in collaboration with European Center for Disease Control (ECDC) and the United Kingdom Health Security Agency (UKHSA), a special late breaking session “Hepatitis of unknown origin” was Read More

Original Article

COVID-19 in Elderly Patients: Risk Factors for Disease Severity

Pınar Korkmaz and others

At the end of 2019, a novel coronavirus was identified as the cause of a cluster of pneumonia cases in Wuhan, a city in the Hubei Province of China. It spread rapidly, resulting in a pandemic throughout the world. In February 2020, the World Health Organization (WHO) named the disease COVID-19. Studies reported that COVID-19 mostly progressed with asymptomatic (...) Read More

Original Article

Predictors of Severity and Mortality in COVID-19: A Retrospective Study from Batman, Turkey

Fethiye Akgül and others

At the beginning of the 21st century, three deadly epidemics related to coronaviruses have struck the world. Severe acute respiratory syndrome (SARS) originated in 2002, Middle East respiratory syndrome (MERS) in 2012, and finally COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in December 2019. COVID-19 (...) Read More

ANTIBACDUS-PAN: Antibacterial Utilization among Adult Patients Before and During COVID-19 Pandemic within 12-Months Period: A Tertiary Hospital Pharmacoepidemiology Study
Original Article

ANTIBACDUS-PAN: Antibacterial Utilization among Adult Patients Before and During COVID-19 Pandemic within 12-Months Period: A Tertiary Hospital Pharmacoepidemiology Study

Ege Anıl Uçar and others

Rational use of medicines (RUM) has been a concern worldwide for half a century, and is of great importance, given that almost half of all prescribed drugs are irrational. The irrational use of drugs can be disastrous and may cause adverse events, creating a (...) Read More

Why to Publish in IDCM

Murat Akova, the Editor-in-Chief of Infectious Diseases and Clinical Microbiology, introduces the journal and invites the authors to submit their research articles and cases to the journal.